遺伝子検査サービスの市場規模および予測（2020年～2030年）、世界および地域シェア、動向、成長機会分析レポート対象範囲サービスタイプ別（予測検査、キャリア検査、出生前検査、新生児スクリーニング、診断用遺伝子検査、その他）、疾患別（癌、代謝性疾患、心血管疾患、その他の疾患）、サービスプロバイダー別（一般検査サービス、リキッドバイオプシーベースのCGP、MRD、MCEDサービス）、地域別（北米、欧州、アジア太平洋地域、中東・アフリカ、南米・中央アメリカ）

Genetic Testing Services Market Size and Forecast (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Predictive Testing, Carrier Testing, Prenatal Testing, Newborn Screening, Diagnostic Genetic Testing, and Others), Disease (Cancer, Metabolic Diseases, Cardiovascular Diseases, and Other Diseases), Service Provider (General Testing Services and Liquid Biopsy-Based CGP, MRD, and MCED Service), and Geography (North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America)

遺伝子検査サービス市場規模は、2022年の34億2,500万米ドルから2030年には105億5,600万米ドルに成長すると予想され、2022年から2030年の年平均成長率は15.1%を記録すると推定されている。遺伝子検査サービス... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
The Insight Partners ザ・インサイトパートナーズ	2023年12月28日	US$5,190 シングルユーザライセンスライセンス・価格情報注文方法はこちら	193	英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

遺伝子検査サービス市場規模は、2022年の34億2,500万米ドルから2030年には105億5,600万米ドルに成長すると予想され、2022年から2030年の年平均成長率は15.1%を記録すると推定されている。

遺伝子検査サービス市場の成長は、遺伝性疾患の有病率の増加、個別化医療に対する認識と受容の高まり、消費者直接遺伝子検査への嗜好の高まりに起因している。しかし、遺伝子検査の社会的・倫理的な意味合いや遺伝子検査サービスの手ごろさが市場成長の妨げとなっている。

中国、インド、メキシコ、ブラジルなどの新興国は、市場関係者に大きな成長機会を提供している。高い成長は、公的医療費の増加、医療インフラの改善、対象患者数の多さに起因している。また、発展途上国における遺伝性疾患とその早期診断に対する意識の高まりにより、遺伝子検査のニーズも高まっている。

遺伝学的サービスの質と利用可能性は、高所得国と中低所得国とで異なる場合がある。例えば、米国、オーストラリア、カナダ、英国、その他の欧州諸国では、遺伝サービスは十分に進歩し、確立され、広範囲に及んでいる。これらのサービスには、新生児スクリーニング、保因者同定スクリーニング、出生前診断が含まれる。しかし、多くの高所得国では、複数の環境で提供される遺伝学的サービスには、まだ改善された評価システムが必要である。

遺伝学的検査手順の容易さと適用可能性は、アジア太平洋地域やその他の発展途上地域における研究開発活動に恩恵をもたらしている。主要な市場プレーヤーは、これらの国々における製品の入手可能性、アクセシビリティ、流通網を改善するために、協定、提携、パートナーシップ、事業拡大などの戦略やイニシアティブに注力している。これにより、早期診断と治療のニーズの高まりに対応することができる。例えば、2019年にブラジルの大手遺伝子検査機関の1つであるGENOMIKAは、全ゲノムシークエンシングと予防医学および臨床遺伝学におけるこれらの検査に関連するすべてのサービスをポートフォリオに組み込むことでベリタスと合意に達した。

中国政府は、経済・社会発展のための第14次5カ年計画（2016～2020年）において、ゲノミクスを重要な戦略分野として位置づけています。2016年、中国科学院は、2030年までに1億人以上のヒトゲノムの塩基配列を決定する92億米ドルの14年プロジェクト「精密医療イニシアティブ」を開始した。2017年12月、中国科学技術省はヒトゲノム研究プロジェクトに協力し、10万人の遺伝子構成を記録した。9つの異なる少数民族の遺伝子データを用いて、研究者たちは遺伝子内の遺伝情報を解読することを望んでいる。さらに、発展途上国におけるDTC遺伝子検査に対する消費者の意識の高まりは、DTC業界に成長機会を提供している。

したがって、発展途上国の新興市場は、市場で活動するプレーヤーに大きな成長機会を提供し、予測期間中の市場成長を後押しすると予想される。

2018年現在、市場で入手可能な遺伝子検査は〜75,000件であり、毎日10件近くの新しい検査が市場に参入している。2023年に発表された研究「米国における遺伝子検査の利用可能性の動向、2012年～2022年」によると、2022年11月現在、米国では～129,624件、世界全体では～197,779件の遺伝子検査が利用可能になり、遺伝子検査レジストリに提出されている。これらの検査は、単一遺伝子の検査から複数の遺伝子を調べるパネル検査へと広がっている。健康データの枯渇という増大する問題を解決するため、医療の分野では人工知能（AI）や機械学習といった臨床ツールの強化がますます中心となっており、ゲノム医療の受容性を向上させる方法として言及されている。現在、放射線科や循環器科などの分野で臨床データを正しく分析・理解するために必要な膨大なデータを処理するために、多くの企業が機械学習に注目している。

市場に出回っている消費者向けの遺伝子検査技術の多くは、機械学習やAIを利用して機能している。多くの点で、病気の遺伝子検査は、これらのプログラムが扱う必要のある膨大な量のデータのため、機械学習に最適な分野である。例えば、ヒトゲノムの解析には何十億ビットもの情報を読み取る必要があり、機械学習が導入される以前は、こうした作業の多くはかなり厄介なものだった。AIは遺伝子データを分析し、臨床専門医の診断をサポートする上で大きな可能性を秘めている。

グーグルには、ヒトゲノムを徹底的にプロットするために使用できるディープ・バリアントと呼ばれるプログラムがあり、人の遺伝情報の全範囲に使用することができる。さらに、国立衛生研究所などの機関は、機械学習とAIが遺伝学とゲノミクスのより良い理解を深める方法に取り組んでいる。したがって、これらのツールをうまく統合することで、臨床医は希少な遺伝病をより効率的かつ効果的に診断できるようになるだろう。

サービスプロバイダーに基づく洞察

サービスプロバイダーに基づいて、遺伝子検査サービス市場は一般検査サービスとリキッドバイオプシーベースのCGP、MRD、MCEDサービスに区分される。2022年には、一般検査サービス分野が市場の最大シェアを占め、2022-2023年に最も高いCAGRを記録すると予測されている。遺伝学的および分子学的検査は、多くの遺伝性疾患、遺伝的関連を有する体性または後天性疾患、および薬理遺伝学的反応を検出するための基本である。遺伝子、染色体、タンパク質の変化を分析するために、複数の遺伝子検査が利用可能である。適切な検査を選択する際、医療提供者は、疑われる疾患やそれらに典型的に関連する遺伝的変異を含むいくつかの要因を考慮する。市場で入手可能ないくつかのタイプの遺伝子検査は、分子、染色体、生化学的メカニズム、および遺伝子発現などに基づいている。

一般的な遺伝子検査は、毛髪、皮膚、血液、羊水（妊娠中の胎児を取り囲む液体）、その他の組織サンプルを用いて行われる。COVID-19 PCR検査は、ウイルスの遺伝物質セグメントに一致するプライマーを使用し、サンプルから抽出した遺伝物質の増幅を可能にし、ウイルスの存在を検出する。

米国疾病予防管理センター（Centers for Disease Control and Prevention）、米国食品医薬品局（US Food and Drug Administration）、世界保健機関（WHO）は、遺伝子検査サービス市場レポート作成時に参照した一次および二次情報源のひとつである。

ページTOPに戻る

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Genetic Testing Services Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. Genetic Testing Services Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Rising Prevalence of Genetic Diseases
5.1.2 Increasing Awareness and Acceptance of Personalized Medicines
5.1.3 Growing Preference for Direct-To-Consumer (DTC) Genetic Testing
5.2 Market Restraints
5.2.1 Social and Ethical Implications of Genetic Testing
5.2.2 Affordability of Genetic Services
5.3 Market Opportunities
5.3.1 Untapped Emerging Markets in Developing Countries
5.4 Future Trends
5.4.1 Artificial Intelligence-Powered Genetic Testing
5.5 Impact Analysis:
6. Genetic Testing Services Market - Global Market Analysis
6.1 Genetic Testing Services Market Revenue (US$ Mn), 2022 – 2030
7. Global Genetic Testing Services Market – Revenue and Forecast to 2030 – by Service Type
7.1 Overview
7.2 Genetic Testing Services Market Revenue Share, by Service Type, 2022 & 2030 (%)
7.3 Predictive Testing
7.3.1 Overview
7.3.2 Predictive Testing: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Carrier Testing
7.4.1 Overview
7.4.2 Carrier Testing: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Prenatal Testing
7.5.1 Overview
7.5.2 Prenatal Testing: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Newborn Screening
7.6.1 Overview
7.6.2 Newborn Screening: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Diagnostic Genetic Testing
7.7.1 Overview
7.7.2 Diagnostic Genetic Testing: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8. Global Genetic Testing Services Market – Revenue and Forecast to 2030 – by Disease
8.1 Overview
8.2 Genetic Testing Services Market Revenue Share, by Disease, 2022 & 2030 (%)
8.3 Cancer
8.3.1 Overview
8.3.2 Cancer: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Cardiovascular Diseases
8.4.1 Overview
8.4.2 Cardiovascular Diseases: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Metabolic Diseases
8.5.1 Overview
8.5.2 Metabolic Diseases: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Other Diseases
8.6.1 Overview
8.6.2 Other Diseases: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
9. Global Genetic Testing Services Market – Revenue and Forecast to 2030 – by Service Provider
9.1 Overview
9.2 Genetic Testing Services Market Revenue Share, by Service Provider, 2022 & 2030 (%)
9.3 General Testing Service
9.3.1 Overview
9.3.2 General Testing Service: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
9.3.2.1 Hospital-Based Laboratories: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
9.3.2.2 Diagnostic Laboratories: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
9.3.2.3 Others: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Liquid biopsy-based CGP, MRD, and MCED Service
9.4.1 Overview
9.4.2 Liquid biopsy-based CGP, MRD, and MCED Service: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
9.4.2.1 Hospital-Based Laboratories: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
9.4.2.2 Diagnostic Laboratories: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
9.4.2.3 Others: Genetic Testing Services Market – Revenue and Forecast to 2030 (US$ Million)
10. Genetic Testing Services Market - Geographical Analysis
10.1 North America Genetic Testing Services Market, Revenue and Forecast To 2030
10.1.1 Overview
10.1.2 North America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.1.3 North America: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.1.4 North America: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.1.5 North America: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.1.5.1 North America: General Testing Service, by Service Provider, 2020–2030 (US$ Million)
10.1.5.2 North America: Liquid Biopsy-Based CGP, MRD, and MCED Service, by Service Provider, 2020–2030 (US$ Million)
10.1.6 North America Genetic Testing Services Market, by Country
10.1.6.1 US
10.1.6.1.1 Overview
10.1.6.1.2 US Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.1.6.1.3 US: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.1.6.1.4 US: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.1.6.1.5 US: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.1.6.2 Canada
10.1.6.2.1 Overview
10.1.6.2.2 Canada Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.1.6.2.3 Canada: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.1.6.2.4 Canada: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.1.6.2.5 Canada: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.1.6.3 Mexico
10.1.6.3.1 Overview
10.1.6.3.2 Mexico Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.1.6.3.3 Mexico: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.1.6.3.4 Mexico: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.1.6.3.5 Mexico: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.2 Europe Genetic Testing Services Market, Revenue and Forecast to 2030
10.2.1 Overview
10.2.2 Europe Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3 Europe: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.2.4 Europe: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.2.5 Europe: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.2.5.1 Europe: General Testing Service, by Service Provider, 2020–2030 (US$ Million)
10.2.5.2 Europe: Liquid Biopsy-Based CGP, MRD, and MCED Service, by Service Provider, 2020–2030 (US$ Million)
10.2.6 Europe Genetic Testing Services Market, by Country
10.2.6.1 UK
10.2.6.1.1 Overview
10.2.6.1.2 UK Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.1.3 UK: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.2.6.1.4 UK: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.2.6.1.5 UK: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.2.6.2 Germany
10.2.6.2.1 Overview
10.2.6.2.2 Germany Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.2.3 Germany: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.2.6.2.4 Germany: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.2.6.2.5 Germany: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.2.6.3 France
10.2.6.3.1 Overview
10.2.6.3.2 France Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.3.3 France: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.2.6.3.4 France: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.2.6.3.5 France: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.2.6.4 Italy
10.2.6.4.1 Overview
10.2.6.4.2 Italy Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.4.3 Italy: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.2.6.4.4 Italy: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.2.6.4.5 Italy: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.2.6.5 Spain
10.2.6.5.1 Overview
10.2.6.5.2 Spain Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.5.3 Spain: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.2.6.5.4 Spain: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.2.6.5.5 Spain: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.2.6.6 Rest of Europe
10.2.6.6.1 Overview
10.2.6.6.2 Rest of Europe Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.2.6.6.3 Rest of Europe: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.2.6.6.4 Rest of Europe: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.2.6.6.5 Rest of Europe: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.3 Asia Pacific Genetic Testing Services Market, Revenue and Forecast to 2030
10.3.1 Overview
10.3.2 Asia Pacific Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3 Asia Pacific: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.3.4 Asia Pacific: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.3.5 Asia Pacific: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.3.5.1 Asia Pacific: General Testing Service, by Service Provider, 2020–2030 (US$ Million)
10.3.5.2 Asia Pacific: Liquid Biopsy-Based CGP, MRD, and MCED Service, by Service Provider, 2020–2030 (US$ Million)
10.3.6 Asia Pacific Genetic Testing Services Market, by Country
10.3.6.1 China
10.3.6.1.1 Overview
10.3.6.1.2 China Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.1.3 China: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.3.6.1.4 China: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.3.6.1.5 China: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.3.6.2 Japan
10.3.6.2.1 Overview
10.3.6.2.2 Japan Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.2.3 Japan: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.3.6.2.4 Japan: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.3.6.2.5 Japan: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.3.6.3 India
10.3.6.3.1 Overview
10.3.6.3.2 India Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.3.3 India: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.3.6.3.4 India: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.3.6.3.5 India: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.3.6.4 Australia
10.3.6.4.1 Overview
10.3.6.4.2 Australia Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.4.3 Australia: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.3.6.4.4 Australia: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.3.6.4.5 Australia: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.3.6.5 South Korea
10.3.6.5.1 Overview
10.3.6.5.2 South Korea Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.5.3 South Korea: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.3.6.5.4 South Korea: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.3.6.5.5 South Korea: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.3.6.6 Rest of Asia Pacific
10.3.6.6.1 Overview
10.3.6.6.2 Rest of Asia Pacific Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.3.6.6.3 Rest of Asia Pacific: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.3.6.6.4 Rest of Asia Pacific: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.3.6.6.5 Rest of Asia Pacific: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.4 Middle East & Africa Genetic Testing Services Market, Revenue and Forecast to 2030
10.4.1 Overview
10.4.2 Middle East & Africa Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3 Middle East & Africa: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.4.4 Middle East & Africa: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.4.5 Middle East & Africa: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.4.5.1 Middle East & Africa: General Testing Service, by Service Provider, 2020–2030 (US$ Million)
10.4.5.2 Middle East & Africa: Liquid Biopsy-Based CGP, MRD, and MCED Service, by Service Provider, 2020–2030 (US$ Million)
10.4.6 Middle East & Africa Genetic Testing Services Market, by Country
10.4.6.1 Saudi Arabia
10.4.6.1.1 Overview
10.4.6.1.2 Saudi Arabia Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.4.6.1.3 Saudi Arabia: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.4.6.1.4 Saudi Arabia: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.4.6.1.5 Saudi Arabia: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.4.6.2 UAE
10.4.6.2.1 Overview
10.4.6.2.2 UAE Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.4.6.2.3 UAE: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.4.6.2.4 UAE: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.4.6.2.5 UAE: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.4.6.3 South Africa
10.4.6.3.1 Overview
10.4.6.3.2 South Africa Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.4.6.3.3 South Africa: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.4.6.3.4 South Africa: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.4.6.3.5 South Africa: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.4.6.4 Rest of Middle East & Africa
10.4.6.4.1 Overview
10.4.6.4.2 Rest of Middle East & Africa Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.4.6.4.3 Rest of Middle East & Africa: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.4.6.4.4 Rest of Middle East & Africa: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.4.6.4.5 Rest of Middle East & Africa: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.5 South & Central America Genetic Testing Services Market, Revenue and Forecast to 2030
10.5.1 Overview
10.5.2 South & Central America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.5.3 South & Central America: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.5.4 South & Central America: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.5.5 South & Central America: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.5.5.1 South & Central America: General Testing Service, by Service Provider, 2020–2030 (US$ Million)
10.5.5.2 South & Central America: Liquid biopsy-based CGP, MRD, and MCED Services, by Service Provider, 2020–2030 (US$ Million)
10.5.6 South & Central America Genetic Testing Services Market, by Country
10.5.6.1 Brazil
10.5.6.1.1 Overview
10.5.6.1.2 Brazil Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.5.6.1.3 Brazil: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.5.6.1.4 Brazil: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.5.6.1.5 Brazil: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.5.6.2 Argentina
10.5.6.2.1 Overview
10.5.6.2.2 Argentina Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.5.6.2.3 Argentina: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.5.6.2.4 Argentina: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.5.6.2.5 Argentina: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
10.5.6.3 Rest of South & Central America
10.5.6.3.1 Overview
10.5.6.3.2 Rest of South & Central America Genetic Testing Services Market Revenue and Forecast to 2030 (US$ Mn)
10.5.6.3.3 Rest of South & Central America: Genetic Testing Services Market, by Service Type, 2020–2030 (US$ Million)
10.5.6.3.4 Rest of South & Central America: Genetic Testing Services Market, by Disease, 2020–2030 (US$ Million)
10.5.6.3.5 Rest of South & Central America: Genetic Testing Services Market, by Service Provider, 2020–2030 (US$ Million)
11. Genetic Testing Services Market–Industry Landscape
11.1 Overview
11.2 Growth Strategies in Genetic Testing Services Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Eurofins Scientific SE
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Exact Sciences Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Laboratory Corp of America Holdings
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4andMe Holding Co
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Ambry Genetics Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Quest Diagnostics Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Illumina Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 F. Hoffmann-La Roche Ltd
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 NeoGenomics Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Centogene AG
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Bio-Rad Laboratories Inc
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms

ページTOPに戻る

Table of Contents

Summary

The genetic testing services market size is expected to grow from US$ 3.425 billion in 2022 to US$ 10.556 billion by 2030; it is estimated to record a CAGR of 15.1% during 2022-2030.

The growth of the genetic testing services market is attributed to the growing prevalence of genetic diseases, increasing awareness and acceptance of personalized medicines, and growing preference for direct-to-consumer genetic testing. However, the social and ethical implications of genetic testing and the affordability of genetic services hinder market growth.

Emerging countries such as China, India, Mexico, and Brazil offer significant growth opportunities to market players. The high growth can be attributed to the increasing public healthcare expenditure, improving healthcare infrastructure, and a large target patient population. The need for genetic testing has also increased owing to a rise in awareness of genetic disorders and their early diagnosis in developing economies.

The quality and availability of genetic services may differ between high-income and low- to middle-income countries. For instance, genetic services are well-advanced, established, and extensive in the US, Australia, Canada, the UK, and other European countries. These services include newborn screening, carrier identification screening, and prenatal diagnosis. Yet, in many high-income countries, genetic services offered in multiple settings still need improved assessment systems.

The ease and applicability of genetic testing procedures have benefitted R&D activities in Asia Pacific and other developing regions worldwide. Major market players focus on strategies and initiatives, such as agreements, collaborations, partnerships, and expansions, to improve their product availability, accessibility, and distribution networks in these countries. This will help them address the growing need for early diagnosis and treatment. For instance, in 2019, GENOMIKA, one of Brazil's leading genetic testing laboratories, reached an agreement with Veritas to incorporate Whole Genome Sequencing and all the services associated with these tests in preventive medicine and clinical genetics into its portfolio.

The Chinese government identifies genomics as an important strategic field in its 14th Five-Year Plan (2016–2020) for economic and social development. In 2016, the Chinese Academy of Sciences launched the Precision Medicine Initiative, a 14-year project worth US$ 9.2 billion to sequence more than 100 million human genomes by 2030. In December 2017, China's Ministry of Science and Technology collaborated with a human genome research project to document the genetic makeup of 100,000 people. Using the genetic data of nine different minority groups, researchers desire to decode hereditary information within genes. In addition, rising consumer awareness regarding DTC genetic tests in developing economies offers growth opportunities to the DTC industry.

Therefore, emerging markets in developing countries are anticipated to offer significant growth opportunities to the players operating in the market and boost the market growth during the forecast period.

As of 2018, there were ~75,000 genetic tests available in the market, with nearly 10 new tests entering the market every day. As per the study "Trends in Availability of Genetic Tests in the United States, 2012–2022," published in 2023, ~129,624 and 197,779 genetic tests in the US and globally, respectively, have been made accessible and submitted to the genetic testing registry as of November 2022. These tests have been extended from single-gene tests to panels that look at multiple genes. To solve the growing problem of health data exhaust, the field of medicine is increasingly revolving around enhanced clinical tools, such as artificial intelligence (AI) and machine learning, which have been mentioned as a way to improve the acceptance of genomic medicine. Today, many companies have turned to machine learning to process the vast amount of data needed to analyze and understand clinical data correctly in fields such as radiology and cardiology.

Many of the consumer-facing genetic testing technologies available in the market use machine learning or AI to function. In numerous ways, genetic testing of diseases is the perfect field for machine learning because of the vast volumes of data that these programs need to struggle with. For example, working on the human genome includes reading billions of bits of information, and many of these tasks were pretty tricky before the introduction of machine learning. AI offers great potential in analyzing genetic data and supporting clinical specialists in diagnosing.

Google has a program called Deep Variant that can now be used to plot the human genome thoroughly and can be used on the full range of a person's genetic information. Moreover, agencies such as the National Institutes of Health are working on ways machine learning and AI can add to a better understanding of genetics and genomics. Thus, by successfully integrating these tools, clinicians will be able to diagnose rare genetic diseases more efficiently and effectively.

Service Provider -Based Insights

Based on the service provider, the genetic testing services market is segmented into general testing services and liquid biopsy-based CGP, MRD, and MCED services. In 2022, the general testing services segment held the largest share of the market and is anticipated to register the highest CAGR during 2022–2023. Genetic and molecular testing is fundamental for detecting many inherited disorders, somatic or acquired diseases with genetic associations, and pharmacogenetic responses. Multiple genetic tests are available to analyze genetic, chromosomal, or protein modifications. When selecting the suitable test, a healthcare provider considers several factors, including suspected conditions and genetic variations typically associated with them. Several types of genetic tests available in the market are based on molecular, chromosomal, and biochemical mechanisms, as well as gene expressions, among others.

General genetic tests are performed on hair, skin, blood, amniotic fluid (the fluid surrounding a fetus during pregnancy), or other tissue samples. COVID-19 PCR tests use primers matching a virus's genetic material segment, allowing the amplification of the genetic material extracted from samples to detect the presence of the virus.

Centers for Disease Control and Prevention, the US Food and Drug Administration, and the World Health Organization are among the primary and secondary sources referred to while preparing the genetic testing services market report.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

The Insight Partners社のバイオテクノロジー分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（医療）の最新刊レポート

The Insight Partners社のバイオテクノロジー分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

よくあるご質問

The Insight Partners社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?